Analysts’ Viewpoint on Market Scenario
The global cutting angioplasty balloons market size is expected to grow at a significant pace in the near future due to increase in the prevalence of cardiovascular diseases and surge in adoption of minimally invasive procedures.
Rise in the geriatric population is also likely to boost the demand for cutting angioplasty balloons during the forecast period. Key players in the industry are developing new and innovative cutting angioplasty balloon products with advanced features such as improved durability, flexibility, and ease of use. This is helping manufacturers to differentiate their products from those of their competitors and attract more customers.
Cutting angioplasty balloons are specialized medical devices used in the treatment of coronary artery disease ― a condition that occurs when plaque builds up in the walls of arteries, narrowing them and restricting blood flow to the heart. This condition can cause chest pain, shortness of breath, and in severe cases, heart attacks.
Angioplasty is a minimally invasive procedure that involves inserting a small balloon catheter into the narrowed artery and inflating it to widen the vessel and improve blood flow. Cutting balloons have microsurgical blades mounted on their surface. These blades make tiny incisions in the plaque buildup, making it easier to compress and reshape the artery.
Cutting angioplasty balloons offers several advantages over traditional angioplasty balloons. They allow for greater precision in plaque removal, reduce the risk of dissection (tearing of the arterial wall), and can lead to better long-term outcomes for patients. These devices are typically employed in more complex cases where traditional angioplasty is unsuccessful or where there is significant plaque buildup.
Cardiovascular diseases (CVDs) are a group of conditions that affect the heart and blood vessels. These conditions include coronary artery disease, heart failure, and stroke. CVDs are the leading cause of death worldwide. The burden of these diseases in low- and middle-income countries is growing at a faster rate than that in high-income countries. This can be ascribed to a surge in the geriatric population, unhealthy dietary habits, sedentary lifestyles, and smoking.
According to the World Health Organization (WHO), CVDs account for approximately 31% of all deaths globally. Moreover, around 17.9 million deaths are recorded each year due to CVD worldwide. Thus, an increase in cases of CVDs is projected to spur the cutting angioplasty balloons market growth in the next few years.
Drug-coated cutting balloon is a major advancement in the field of angioplasty. It is designed to deliver drugs directly to the site of the plaque buildup, reducing the risk of restenosis (re-narrowing of the artery) and the need for repeat procedures. Drug-coated cutting balloons have demonstrated promising results in clinical trials. These devices reduce the need for repeat procedures. Therefore, R&D of new devices is augmenting the cutting angioplasty balloons market value.
Vendors in the industry are developing smaller and more flexible angioplasty cutting balloons to improve patient comfort and reduce the risk of complications. They are also using advanced imaging technologies, such as Intravascular Ultrasound (IVUS) and optical coherence tomography (OCT), to boost the accuracy of the procedure.
According to the latest cutting angioplasty balloons market trends, the drug-coated cutting balloons product type segment is expected to dominate the industry during the forecast period. The development of new coatings and materials is boosting the segment. Drug-coated cutting balloons are designed to deliver drugs directly to the site of plaque buildup in the arteries. This targeted delivery of drugs reduces the risk of restenosis, which is the recurrence of narrowing in the arteries that can lead to repeat procedures.
Drug-coated cutting balloons have emerged as a highly effective alternative to traditional balloon angioplasty procedures. They are specifically engineered to make contact with the arterial wall and deliver drugs that help prevent the reoccurrence of plaque buildup. Drug-coated cutting balloons prevent the use of additional medical interventions, such as stenting or other implantable devices. Thus, patients experience less pain, a faster recovery period, and a reduced risk of complications.
The coronary artery disease segment dominated the industry in 2022, as per the latest cutting angioplasty balloons market research. The growth of the segment can be ascribed to the high prevalence of coronary artery disease worldwide. This condition can lead to a heart attack and typically requires more complex and advanced procedures for effective treatment.
Cutting angioplasty balloons is an essential tool in the treatment of coronary artery disease. It is used to widen the blocked or narrowed arteries, which helps restore blood flow to the heart. These balloons are designed to make precise incisions in the plaque, resulting in a more significant expansion of the artery.
According to the latest cutting angioplasty balloons market analysis, the hospital end-user segment is projected to hold the largest share during the forecast period. Hospitals have a larger patient pool and greater resources to invest in advanced technologies, enabling them to offer breakthrough medical devices such as cutting angioplasty balloons. These medical institutions have the necessary infrastructure, skilled personnel, and advanced equipment to perform complex procedures that are required for the treatment of cardiovascular diseases.
Hospitals are a preferred choice for patients who require angioplasty procedures, as they are often viewed as the most reliable and safest option. The level of expertise available in hospitals, along with access to advanced medical technologies, provides patients with the confidence that they would receive the best possible care. The high volume of patients that hospitals receive allows for more extensive research and development of new medical technologies, further advancing the efficacy and safety of these devices.
North America is estimated to dominate the global market from 2023 to 2031. Increase in the incidence of chronic diseases and rise in the geriatric population are driving market progress. The U.S. is the largest market for cutting angioplasty balloons due to the presence of well-established healthcare infrastructure and favorable reimbursement policies.
The industry in Asia Pacific is expected to grow at a significant pace in the near future. Surge in the prevalence of cardiovascular diseases and growth in adoption of minimally invasive procedures are boosting the cutting angioplasty balloons market dynamics in the region. The industry in China is driven by increase in the geriatric population and rise in cases of heart disease.
Presence of well-established healthcare infrastructure and surge in adoption of advanced technologies are augmenting the market in Japan. The industry in India is propelled by growth in investment in healthcare infrastructure.
Abbott, Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd., Spectranetics (Philips Healthcare), Terumo Corporation, TriReme Medical, LLC (QT Vascular Ltd.), and Vascular Concepts Limited are key entities operating in this industry.
Key players have been profiled in the cutting angioplasty balloons market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Higher cost of cutting angioplasty balloons than their traditional counterparts is a major challenge limiting their adoption, particularly in developing countries where cost constraints may be more pronounced. Thus, manufacturers are optimizing product costs by streamlining their operations, improving supply chain management, and adopting new technologies. This helps them to increase their profitability and cutting angioplasty balloons market share.
In September 2022, Lepu Medical Technology (Beijing) Co., Ltd. received marketing approval from China’s National Medical Products Administration for its Vesscide peripheral cutting balloon intended for use in the treatment of peripheral arterial disease.
Attribute |
Detail |
Market Size Value in 2022 |
US$ 205.9 Mn |
Market Forecast Value in 2031 |
More than US$ 360.0 Mn |
Compound Annual Growth Rate (CAGR) |
6.4% |
Forecast Period |
2023–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global market was valued at US$ 205.9 Mn in 2022.
It is projected to reach more than US$ 360.0 Mn by the end of 2031.
It is anticipated to be 6.4% from 2023 to 2031.
Rise in prevalence of cardiovascular diseases and technological advancements in cutting balloon technology.
The coronary artery disease segment dominated the industry and held 60.0% share in 2022.
North America is expected to account for largest share from 2023 to 2031.
Abbott, Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd., Spectranetics (Philips Healthcare), Terumo Corporation, TriReme Medical, LLC (QT Vascular Ltd.), and Vascular Concepts Limited.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cutting Angioplasty Balloons Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type
4.1.2. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Cutting Angioplasty Balloons Market Analysis and Forecast, 2017–2031
4.3.1. Global Cutting Angioplasty Balloons Market Revenue Projection (US$ Mn)
5. Market Outlook
5.1. Key Industry Development
5.2. Cardiovascular Disease and Peripheral Disease Outlook
5.3. COVID-19 Impact Analysis
6. Global Cutting Angioplasty Balloons Market Analysis and Forecast, by Product Type
6.1. Key Findings/Developments
6.2. Introduction & Definition
6.3. Global Cutting Angioplasty Balloons Market Value Forecast, by Product Type, 2017–2031
6.3.1. Drug-coated Cutting Balloons
6.3.2. Conventional Cutting Balloons
6.3.3. Scoring Balloons
6.4. Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type
7. Global Cutting Angioplasty Balloons Market Analysis and Forecast, by Application
7.1. Key Findings/Developments
7.2. Introduction & Definition
7.3. Global Cutting Angioplasty Balloons Market Value Forecast, by Application, 2017–2031
7.3.1. Coronary Artery Disease
7.3.2. Peripheral Artery Disease
7.4. Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application
8. Global Cutting Angioplasty Balloons Market Analysis and Forecast, by End-user
8.1. Key Findings/Developments
8.2. Introduction & Definition
8.3. Global Cutting Angioplasty Balloons Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Cardiac Centers
8.3.3. Others
8.4. Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user
9. Global Cutting Angioplasty Balloons Market Analysis and Forecast, by Region
9.1. Geographical Representation
9.2. Global Cutting Angioplasty Balloons Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by Region
10. North America Cutting Angioplasty Balloons Market Analysis and Forecast
10.1. North America Cutting Angioplasty Balloons Market Value Share Analysis, by Country, 2022–2031
10.2. North America Cutting Angioplasty Balloons Market Value Forecast, by Country, 2017–2031
10.2.1. U.S.
10.2.2. Canada
10.3. North America Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022–2031
10.4. North America Cutting Angioplasty Balloons Market Value Forecast, by Product Type, 2017–2031
10.4.1. Drug-coated Cutting Balloons
10.4.2. Conventional Cutting Balloons
10.4.3. Scoring Balloons
10.5. North America Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022–2031
10.6. North America Cutting Angioplasty Balloons Market Value Forecast, by Application, 2017–2031
10.6.1. Coronary Artery Disease
10.6.2. Peripheral Artery Disease
10.7. North America Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022–2031
10.8. North America Cutting Angioplasty Balloons Market Value Forecast, by End-user, 2017–2031
10.8.1. Hospitals
10.8.2. Cardiac Centers
10.8.3. Others
10.9. North America Cutting Angioplasty Balloons Market Attractiveness Analysis (2023–2031)
10.9.1. By Country
10.9.2. By Product Type
10.9.3. By Application
10.9.4. By End-user
11. Europe Cutting Angioplasty Balloons Market Analysis and Forecast
11.1. Europe Cutting Angioplasty Balloons Market Value Forecast, by Country/Sub-region, 2017–2031
11.1.1. Germany
11.1.2. France
11.1.3. U.K.
11.1.4. Spain
11.1.5. Italy
11.1.6. Rest of Europe
11.2. Europe Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022–2031
11.3. Europe Cutting Angioplasty Balloons Market Value Forecast, by Product Type, 2017–2031
11.3.1. Drug-coated Cutting Balloons
11.3.2. Conventional Cutting Balloons
11.3.3. Scoring Balloons
11.4. Europe Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022–2031
11.5. Europe Cutting Angioplasty Balloons Market Value Forecast, by Application, 2017–2031
11.5.1. Coronary Artery Disease
11.5.2. Peripheral Artery Disease
11.6. Europe Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022–2031
11.7. Europe Cutting Angioplasty Balloons Market Value Forecast, by End-user, 2017–2031
11.7.1. Hospitals
11.7.2. Cardiac Centers
11.7.3. Others
11.8. Europe Cutting Angioplasty Balloons Market Attractiveness Analysis (2023–2031)
11.8.1. By Country/Sub-region
11.8.2. By Product Type
11.8.3. By Application
11.8.4. By End-user
12. Asia Pacific Cutting Angioplasty Balloons Market Analysis and Forecast
12.1. Asia Pacific Cutting Angioplasty Balloons Market Value Forecast, by Country/Sub-region, 2017–2031
12.1.1. China
12.1.2. Japan
12.1.3. India
12.1.4. Australia & New Zealand
12.1.5. Rest of Asia Pacific
12.2. Asia Pacific Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022–2031
12.3. Asia Pacific Cutting Angioplasty Balloons Market Value Forecast, by Product Type, 2017–2031
12.3.1. Drug-coated Cutting Balloons
12.3.2. Conventional Cutting Balloons
12.3.3. Scoring Balloons
12.4. Asia Pacific Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022–2031
12.5. Asia Pacific Cutting Angioplasty Balloons Market Value Forecast, by Application, 2017–2031
12.5.1. Coronary Artery Disease
12.5.2. Peripheral Artery Disease
12.6. Asia Pacific Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022–2031
12.7. Asia Pacific Cutting Angioplasty Balloons Market Value Forecast, by End-user, 2017–2031
12.7.1. Hospitals
12.7.2. Cardiac Centers
12.7.3. Others
12.8. Asia Pacific Cutting Angioplasty Balloons Market Attractiveness Analysis (2023–2031)
12.8.1. By Country/Sub-region
12.8.2. By Product Type
12.8.3. By Application
12.8.4. By End-user
13. Latin America Cutting Angioplasty Balloons Market Analysis and Forecast
13.1. Latin America Cutting Angioplasty Balloons Market Value Forecast, by Country/Sub-region, 2017-2027
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Rest of Latin America
13.2. Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022–2031
13.3. Latin America Cutting Angioplasty Balloons Market Value Forecast, by Product Type, 2017–2031
13.3.1. Drug-coated Cutting Balloons
13.3.2. Conventional Cutting Balloons
13.3.3. Scoring Balloons
13.4. Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022–2031
13.5. Latin America Cutting Angioplasty Balloons Market Value Forecast, by Application, 2017–2031
13.5.1. Coronary Artery Disease
13.5.2. Peripheral Artery Disease
13.6. Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022–2031
13.7. Latin America Cutting Angioplasty Balloons Market Value Forecast, by End-user, 2017–2031
13.7.1. Hospitals
13.7.2. Cardiac Centers
13.7.3. Others
13.8. Latin America Cutting Angioplasty Balloons Market Attractiveness Analysis (2023–2031)
13.8.1. By Country/Sub-region
13.8.2. By Product Type
13.8.3. By Application
13.8.4. By End-user
14. Middle East & Africa Cutting Angioplasty Balloons Market Analysis and Forecast
14.1. Middle East & Africa Cutting Angioplasty Balloons Market Value Forecast, by Country/Sub-region, 2017–2031
14.1.1. GCC Countries
14.1.2. South Africa
14.1.3. Rest of Middle East & Africa
14.2. Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022–2031
14.3. Middle East & Africa Cutting Angioplasty Balloons Market Value Forecast, by Product Type, 2017–2031
14.3.1. Drug-coated Cutting Balloons
14.3.2. Conventional Cutting Balloons
14.3.3. Scoring Balloons
14.4. Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022–2031
14.5. Middle East & Africa Cutting Angioplasty Balloons Market Value Forecast, by Application, 2017–2031
14.5.1. Coronary Artery Disease
14.5.2. Peripheral Artery Disease
14.6. Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022–2031
14.7. Middle East & Africa Cutting Angioplasty Balloons Market Value Forecast, by End-user, 2017–2031
14.7.1. Hospitals
14.7.2. Cardiac Centers
14.7.3. Others
14.8. Middle East & Africa Cutting Angioplasty Balloons Market Attractiveness Analysis (2023–2031)
14.8.1. By Country/Sub-region
14.8.2. By Product Type
14.8.3. By Application
14.8.4. By End-user
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.2.1. Abbott (HQ, Business Segments, Employee Strength)
15.2.1.1. Company Details
15.2.1.2. Company Description
15.2.1.3. Business Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Financial Analysis
15.2.1.6. Strategic Overview
15.2.2. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)
15.2.2.1. Company Details
15.2.2.2. Company Description
15.2.2.3. Business Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. B. Braun Melsungen AG (HQ, Business Segments, Employee Strength)
15.2.3.1. Company Details
15.2.3.2. Company Description
15.2.3.3. Business Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Cook Medical (HQ, Business Segments, Employee Strength)
15.2.4.1. Company Details
15.2.4.2. Company Description
15.2.4.3. Business Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Cordis (HQ, Business Segments, Employee Strength)
15.2.5.1. Company Details
15.2.5.2. Company Description
15.2.5.3. Business Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Financial Analysis
15.2.5.6. Strategic Overview
15.2.6. Medtronic (HQ, Business Segments, Employee Strength)
15.2.6.1. Company Details
15.2.6.2. Company Description
15.2.6.3. Business Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Financial Analysis
15.2.6.6. Strategic Overview
15.2.7. MicroPort Scientific Corporation (HQ, Business Segments, Employee Strength)
15.2.7.1. Company Details
15.2.7.2. Company Description
15.2.7.3. Business Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Financial Analysis
15.2.7.6. Strategic Overview
15.2.8. Opto Circuits (India) Ltd.
15.2.8.1. Company Details
15.2.8.2. Company Description
15.2.8.3. Business Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Financial Analysis
15.2.8.6. Strategic Overview
15.2.9. Spectranetics (Philips Healthcare)
15.2.9.1. Company Details
15.2.9.2. Company Description
15.2.9.3. Business Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Financial Analysis
15.2.9.6. Strategic Overview
15.2.10. Terumo Corporation (HQ, Business Segments, Employee Strength)
15.2.10.1. Company Details
15.2.10.2. Company Description
15.2.10.3. Business Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Financial Analysis
15.2.10.6. Strategic Overview
15.2.11. TriReme Medical, LLC (QT Vascular Ltd.) (HQ, Business Segments, Employee Strength)
15.2.11.1. Company Details
15.2.11.2. Company Description
15.2.11.3. Business Overview
15.2.11.4. SWOT Analysis
15.2.11.5. Financial Analysis
15.2.11.6. Strategic Overview
15.2.12. Vascular Concepts Limited (HQ, Business Segments, Employee Strength)
15.2.12.1. Company Details
15.2.12.2. Company Description
15.2.12.3. Business Overview
15.2.12.4. SWOT Analysis
15.2.12.5. Financial Analysis
15.2.12.6. Strategic Overview
List of Tables
Table 01: Global Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: Europe Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 14: Asia Pacific Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 18: Latin America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 22: Middle East & Africa Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Cutting Angioplasty Balloons Market Value Share, by Product Type
Figure 03: Global Cutting Angioplasty Balloons Market Value Share, by Application, 2022
Figure 04: Global Cutting Angioplasty Balloons Market Value Share, by End-user, 2022
Figure 05: Global Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 06: Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 07: Global Cutting Angioplasty Balloons Market Value (US$ Mn), by Drug-coated Cutting Balloons, 2017‒2031
Figure 08: Global Cutting Angioplasty Balloons Market Value (US$ Mn), by Conventional Cutting Balloons, 2017‒2031
Figure 09: Global Cutting Angioplasty Balloons Market (US$ Mn), by Scoring Balloons, 2017–2031
Figure 10: Global Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022 and 2031
Figure 11: Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 12: Global Cutting Angioplasty Balloons Market Revenue (US$ Mn), by Coronary Artery Disease, 2017–2031
Figure 13: Global Cutting Angioplasty Balloons Market Revenue (US$ Mn), by Peripheral Artery Disease, 2017–2031
Figure 14: Global Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 15: Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Cutting Angioplasty Balloons Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 17: Global Cutting Angioplasty Balloons Market Revenue (US$ Mn), by Cardiac Centers, 2017–2031
Figure 18: Global Cutting Angioplasty Balloons Market Revenue (US$ Mn), by Others
Figure 19: Global Cutting Angioplasty Balloons Market Value Share Analysis, by Region, 2022 and 2031
Figure 20: Global Cutting Angioplasty Balloons Market Attractiveness Analysis, by Region, 2023–2031
Figure 21: North America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 22: North America Cutting Angioplasty Balloons Market Value Share Analysis, by Country, 2022 and 2031
Figure 23: North America Cutting Angioplasty Balloons Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 25: North America Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 26: North America Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022 and 2031
Figure 27: North America Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 28: North America Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 30: Europe Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 31: Europe Cutting Angioplasty Balloons Market Value Share Analysis, by Country, 2022 and 2031
Figure 32: Europe Cutting Angioplasty Balloons Market Attractiveness Analysis, by Country, 2023–2031
Figure 33: Europe Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 34: Europe Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 35: Europe Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022 and 2031
Figure 36: Europe Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 37: Europe Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 38: Europe Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 39: Asia Pacific Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 40: Asia Pacific Cutting Angioplasty Balloons Market Value Share Analysis, by Country, 2022 and 2031
Figure 41: Asia Pacific Cutting Angioplasty Balloons Market Attractiveness Analysis, by Country, 2023–2031
Figure 42: Asia Pacific Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 43: Asia Pacific Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 45: Asia Pacific Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 46: Asia Pacific Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 47: Asia Pacific Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 48: Latin America Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 49: Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by Country, 2022 and 2031
Figure 50: Latin America Cutting Angioplasty Balloons Market Attractiveness Analysis, by Country, 2023–2031
Figure 45: Asia Pacific Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 51: Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 52: Latin America Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 53: Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022 and 2031
Figure 54: Latin America Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 55: Latin America Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 56: Latin America Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 57: Middle East & Africa Cutting Angioplasty Balloons Market Value (US$ Mn) Forecast, 2017–2031
Figure 58: Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by Country, 2022 and 2031
Figure 59: Middle East & Africa Cutting Angioplasty Balloons Market Attractiveness Analysis, by Country, 2023–2031
Figure 60: Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 61: Middle East & Africa Cutting Angioplasty Balloons Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 62: Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by Application, 2022 and 2031
Figure 63: Middle East & Africa Cutting Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 64: Middle East & Africa Cutting Angioplasty Balloons Market Value Share Analysis, by End-user, 2022 and 2031
Figure 65: Middle East & Africa Cutting Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031